New Chemical Series Epilepsy PK/PD Screen
March 28, 2019
The Scientific Team at Xyzagen was involved in supporting the in vivo medicinal chemistry screening for a client who was evaluating a new chemical series
The Scientific Team at Xyzagen was involved in supporting the in vivo medicinal chemistry screening for a client who was evaluating a new chemical series
Consultants at Xyzagen were involved in supporting the biopharmaceutics component of an extended release formulation technology transfer for a client who owned the NDA for
